Ruxolitinib add-on in corticosteroid-refractory graft-vs-host disease after allogeneic stem cell transplantation: Results from a retrospective study on 38 Chinese patients

BACKGROUND: Graft-vs-host disease (GVHD) is a major cause of mortality after allogeneic hematopoietic stem cell transplantation. Some patients have steroid-refractory (SR) GVHD. AIM: To evaluate the effect and safety of ruxolitinib add-on in the treatment of patients with SR acute (a) and chronic (c...

Descripción completa

Detalles Bibliográficos
Autores principales: Dang, Si-Hua, Liu, Qin, Xie, Rong, Shen, Na, Zhou, Shu, Shi, Wei, Liu, Wen, Zou, Ping, You, Yong, Zhong, Zhao-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103980/
https://www.ncbi.nlm.nih.gov/pubmed/32258077
http://dx.doi.org/10.12998/wjcc.v8.i6.1065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103980/
https://www.ncbi.nlm.nih.gov/pubmed/32258077
http://dx.doi.org/10.12998/wjcc.v8.i6.1065

Ejemplares similares